TY - JOUR
T1 - Novel candidates synthesis of indenopyrazole, indenoazine and indenothiophene, with anticancer and in silico studies
AU - Abdellattif, Magda H.
AU - Assy, Mohammed Gomma
AU - Elfarargy, Ahmed
AU - Ramadan, Fawzy
AU - Elgendy, Marwa S.
AU - Emwas, Abdul Hamid M.
AU - Jaremko, Mariusz
AU - Shehab, Wesam S.
N1 - Publisher Copyright:
© 2024 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2024
Y1 - 2024
N2 - Aim: The indandione nucleus, is one of the most amazing nuclei in medicinal chemistry, is used to design new derivatives. Methods & materials: Novel indandione derivatives are prepared with different electrophilic and nucleophilic reagents to yield 3, 4, 8, 11, 14, 16, 19, 20, 21, 22 and 23. Compounds 8, 11, 16, 20 and 23 are investigated against OVCAR-3 and HeLa, using LLC-MK2 and cis-Pt as references. in silico and spectral studies were analyzed for the selected compounds. Results: Compounds 20 and 23 at 100 ns were the most potent compounds, so molecular dynamics studies were performed. Conclusion: Compound 23 was the most active toward the HeLa cervical cell line, and compound 20 was the most active toward the Ovcar-3 cell line.
AB - Aim: The indandione nucleus, is one of the most amazing nuclei in medicinal chemistry, is used to design new derivatives. Methods & materials: Novel indandione derivatives are prepared with different electrophilic and nucleophilic reagents to yield 3, 4, 8, 11, 14, 16, 19, 20, 21, 22 and 23. Compounds 8, 11, 16, 20 and 23 are investigated against OVCAR-3 and HeLa, using LLC-MK2 and cis-Pt as references. in silico and spectral studies were analyzed for the selected compounds. Results: Compounds 20 and 23 at 100 ns were the most potent compounds, so molecular dynamics studies were performed. Conclusion: Compound 23 was the most active toward the HeLa cervical cell line, and compound 20 was the most active toward the Ovcar-3 cell line.
KW - anticancer
KW - in silico studies
KW - indenopyrane
KW - indenopyrazole
KW - mercaptopyrazole
UR - http://www.scopus.com/inward/record.url?scp=85195173293&partnerID=8YFLogxK
U2 - 10.1080/17568919.2024.2351350
DO - 10.1080/17568919.2024.2351350
M3 - Article
C2 - 39190476
AN - SCOPUS:85195173293
SN - 1756-8919
VL - 16
SP - 1429
EP - 1447
JO - Future Medicinal Chemistry
JF - Future Medicinal Chemistry
IS - 14
ER -